Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_assertion type Assertion NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_head.
- NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_assertion description "[Patients with breast tumors characterized by high CysLT(1)R and low CysLT(2)R expression levels exhibited increased risk of cancer-induced death in univariate analysis for both the total patient group (hazard ratio [HR] = 2.88, 95% confidence interval [CI] = 1.11-7.41), as well as patients with large (>20 mm) tumors (HR = 5.08, 95% CI = 1.39-18.5).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_provenance.
- NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_assertion evidence source_evidence_literature NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_provenance.
- NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_assertion SIO_000772 20824707 NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_provenance.
- NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_assertion wasDerivedFrom befree-20150227 NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_provenance.
- NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_assertion wasGeneratedBy ECO_0000203 NP853098.RAdKhPsfppFcuq-9kpEy6toNXswLlFbz2uUg6kBJg3_Pg130_provenance.